Bright, Sandra A <br/><br/>
Sequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatment.  [electronic resource] 

 -  Biochemical pharmacology  Jul 2010 
 - 31-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-2968 
<br/><br/><label>Standard No.: </label>10.1016/j.bcp.2010.02.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Benzamides<br/>Down-Regulation<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Synergism<br/>Flavonoids--pharmacology<br/>Humans<br/>Imatinib Mesylate<br/>Inhibitor of Apoptosis Proteins<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Microtubule-Associated Proteins--metabolism<br/>Oxazepines--pharmacology<br/>Piperazines--pharmacology<br/>Piperidines--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyrimidines--pharmacology<br/>Pyrroles--pharmacology<br/>Survivin